RENOVIS BIPOLAR HIP SYSTEM— 510(k) K131354

Name: FDA 510(k) clearance K131354
Creator: U.S. Food and Drug Administration
Published: 2013-09-19

Substantially Equivalent

Renovis Surgical Technologies, LLC

FDA 510(k) clearance K131354 for RENOVIS BIPOLAR HIP SYSTEM, Substantially Equivalent on 2013-09-19. Applicant: Renovis Surgical Technologies, LLC. Device class: 2.

Clearance details

Applicant: Renovis Surgical Technologies, LLC
Product code: Code KWY
Device class: Class 2
Regulation: 21 CFR 888.3390
Advisory panel: Orthopedic
Date received: 2013-05-10
Decision date: 2013-09-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Ashland, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KWY

view all

K253357 — b-ONE® Bipolar Head2026-04-13
K243634 — Maxx Libertas Bipolar Hip Head (Bipolar Hip)2025-08-25
K231526 — CORAIL Cemented Femoral Stem2023-12-19
K223441 — SpaceFlex Acetabular Cup2023-03-23
K221794 — Vario-Cup System2022-07-20

More clearances from Renovis Surgical Technologies, LLC

view all

K132312 — RENOVIS TESERA TRABECULAR TECHNOLOGY (T3) ACETABULAR SHELL SYSTEM2014-04-11
K131122 — S128 ANTERIOR LUMBAR INTERBODY FUSION (ALIF) SYSTEM2013-09-18
K120038 — A200 KNEE SYSTEM2013-02-14
K112897 — RENOVIS SURGICAL HIP JOINT REPLACEMENT PROSTHESIS2012-06-13
K111940 — S 100 PEDICLE SCREW SYSTEM2012-05-15

Adverse events under product code KWY

product code KWY

Death: 3
Injury: 2,049
Total: 2,052

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.